MACQUARIE GROUP LTD - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2022$25,000
+8.7%
1,834
-64.7%
0.00%
Q2 2022$23,000
-8.0%
5,1950.0%0.00%
Q1 2022$25,000
-35.9%
5,1950.0%0.00%
Q4 2021$39,000
+34.5%
5,1950.0%0.00%
Q3 2021$29,000
-14.7%
5,1950.0%0.00%
Q2 2021$34,000
-19.0%
5,1950.0%0.00%
Q1 2021$42,000
-4.5%
5,195
-23.5%
0.00%
Q4 2020$44,000
+83.3%
6,7880.0%0.00%
Q3 2020$24,000
-22.6%
6,7880.0%0.00%
Q2 2020$31,000
+3000.0%
6,788
+3101.9%
0.00%
Q3 2019$1,000
-99.9%
212
-99.9%
0.00%
-100.0%
Q1 2019$949,000
-69.6%
350,000
-46.2%
0.00%
-66.7%
Q4 2018$3,120,000
-49.3%
650,0000.0%0.01%
-40.0%
Q3 2018$6,156,000
-44.2%
650,000
-42.6%
0.01%
-47.4%
Q2 2018$11,024,000
-7.3%
1,133,000
+0.3%
0.02%
-13.6%
Q1 2018$11,888,000
+61.7%
1,130,000
-1.5%
0.02%
+69.2%
Q4 2017$7,354,000
+13.1%
1,147,300
+35.0%
0.01%
+8.3%
Q3 2017$6,503,000
+7.6%
850,0000.0%0.01%
+9.1%
Q2 2017$6,044,000
+123.1%
850,000
+21.4%
0.01%
+120.0%
Q1 2017$2,709,000
+89.7%
700,0000.0%0.01%
+66.7%
Q4 2016$1,428,000
-42.7%
700,000
-24.7%
0.00%
-40.0%
Q3 2016$2,492,000
-56.5%
930,000
-50.0%
0.01%
-16.7%
Q2 2016$5,728,000
+40.0%
1,860,000
+287.5%
0.01%
-25.0%
Q1 2016$4,090,000
-29.9%
480,000
+11.6%
0.01%
-33.3%
Q4 2015$5,835,000
+41.4%
430,0000.0%0.01%
+33.3%
Q3 2015$4,128,000
-33.2%
430,0000.0%0.01%
-25.0%
Q2 2015$6,183,000
+60.6%
430,0000.0%0.01%
+50.0%
Q1 2015$3,849,000
+117.6%
430,000
+48.3%
0.01%
+100.0%
Q4 2014$1,769,000
-42.4%
290,0000.0%0.00%
-42.9%
Q3 2014$3,071,000
-2.2%
290,000
+9.4%
0.01%0.0%
Q2 2014$3,140,000
-21.5%
265,000
-1.1%
0.01%0.0%
Q1 2014$4,002,000
+324.8%
268,077
+317.4%
0.01%
+250.0%
Q4 2013$942,000
-5.8%
64,230
+9.3%
0.00%0.0%
Q3 2013$1,000,000
+8.0%
58,740
+5.3%
0.00%0.0%
Q2 2013$926,00055,7900.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders